NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
Clinical Trials
12 trialsNCT05454358 2025-12-15
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
Fudan University
Phase 2/3 Terminated
NCT05316935 2025-08-11
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Fudan University
Phase 2/3 Recruiting
NCT06379113 2025-08-11
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Fudan University
Phase 2/3 Recruiting
NCT05523609 2023-12-01
Vitamin D and Calcium Supplementation in Breast Cancer
Tanta University
Phase 2/3 Unknown
NCT02221999 2023-08-29
SHPD002
RenJi Hospital
Phase 2/3 Active not recruiting
NCT02692755 2021-09-28
PALINA
Georgetown University
Phase 2/3 Completed
NCT03285802 2020-02-05
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Greater Baltimore Medical Center
Phase 2/3 Completed
NCT03507465 2018-04-25
Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer
Guangdong Provincial People's Hospital
Phase 2/3 Unknown
NCT03440359 2018-02-26
Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
Eastern Virginia Medical School
Phase 2/3 Completed
NCT03373708 2017-12-18
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2/3 Unknown
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated